Skip to main content
. 2014 May;62(5):554–560. doi: 10.4103/0301-4738.133485

Figure 2.

Figure 2

Morphologic and morphometric data that we analyzed before and after anti-VEGF treatment: central retinal thickness (double-head red arrows), fibrosis (blue arrow) and photoreceptor layer defects (orange arrow). “A” shows the pre-treatment B-scan, and “B” is the B-scan of the same area 12 months after treatment began